pharmaphorum2 天
FDA knocks back Zealand's dasiglucagon once again
Another drugs that may be used off-label for GHI include Xeris' Gvoke brand of glucagon in pre-filled syringe and pen injector formulations, which was approved in 2019 as a hypoglycaemia rescue ...
来自MSN4 个月
There's a New, Lower-Cost Version of Weight Loss Drug Zepbound—Here's What to Know
Zepbound, a brand-name version of tirzepatide, is part of a class of medications called glucagon-like peptide ... syringes rather than preloaded injector pens). “These new vials not only help ...
pharmaphorum7 天
CHMP backs Lilly’s Baqsimi as non-injectable for severe low blood sugar
In the US, Baqsimi is now competing head-to-head with Xeris’ Gvoke, pre-filled syringe and pen injector formulations of glucagon that don’t require the mixing steps and can be used in patients ...
McKnight's Long-Term Care News1 个月
FDA approves first generic liraglutide once-daily injection
(HealthDay News) — The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon ... the once-daily injection (18 ...